Skip to main content

Table 3 Prescription of antipsychotic drugs at admission and discharge, p-values of differences and chlorpromazine equivalent doses at discharge (n = 486).

From: Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

FGA     
Antipsychotic drug Admission N(%) Discharge
N(%)
Adjusted P-value for the difference* Chlorpromazine equivalent dose at discharge
mean (SD) range
Low-potency     
Levomepromazine (Nozinan®) 31(6.4) 39(8.2) 0.248 87 (99) 10–400
Chlorpromazine (Largactil®) 29(6.0) 28(5.8) 0.793 171 (104) 4–400
Klorprotixene (Truxal ®) 13(2.7) 18(3.7) 0.501 250 (145) 111–667
Thioridazine (Melleril®) 1(0.2) 1(0.2)   75
Medium potency     
Perphenazine (Trilafon®) 24(4.9) 17(3.5) 0.248 187 (121) 50–400
Perphenazine decanoate (Trilafon depot®) 37(7.6) 49(10.1) 0.049 488 (243) 203–1624
Perphenazine total number patients 60(12.4) 65(13.4) 0.537  
Zuclopentixol (Cisordinol®) 15(3.1) 21(4.3) 0.501 58 (27) 28–128
Zuclopenthixol decanoate (Cisordinol Depot®) 39(8.0) 49(10.1) 0.247 115 (61) 34–357
Zuclopenthixol total number patients 51(10.5) 68(14.0) 0.049  
Dixyrazine (Esucos®) 4(0.8) 6(1.2) 0.536 300 (300-300)
Prochlorperazine (Stemetil®) 1(0.2) 1(0.2)   1000
High-potency     
Haloperidol (Haldol®) 8(1.7) 10(2.0) 0.613 144 (85) 33–267
Haloperidol decanoate (Haldol depot®) 6(1.2) 7(1.4) 0.524 400 (164) 179–714
Haloperidol total number patients 14(2.9) 15(3.1) 0.793  
Flupenthixol (Fluanxol®) 2(0.4) 3(0.6) 0.537 266 (85) 33–267
Flupenthixol decanoate (Fluanxol depot®) 5(1.0) 6(1.2) 0.793 247 (129) 153–429
Flupentixol total number patients 7(1.4) 9(1.9) 0.613  
SGA     
Olanzapine (Zyprexa®) 122 (25.1) 141 (29.0) 0.049 350 (137) 100–800
Risperidone (Risperdal®) 39(8.0) 43(8.9) 0.613 234 (107) 67–467
Risperidone long-acting injection (Risperdal Consta®) 57(11.7) 62(12.8) 0.565 311 (94) 179–536
Risperidon total number patients 91 (18.7) 93 (19.1) 0.793  
Quetiapine (Seroquel®) 42(8.6) 46(9.5) 0.613 690 (533) 33–2800
Clozapine (Leponex®, Clozapine®) 37(7.6) 39(8.0) 0.524  
Aripiprazole (Abilify®) 29(6.0) 30(6.2) 0.793 285 (94) 133–400
Ziprazidone (Zeldox®) 23(4.7) 24(4.9) 0.793 173 (90) 33–266
Amisulpride (Solian®) 11(2.3) 14(2.9) 0.537 600 (353) 100–1200
Sertindole (Serdolect®) 0(0) 1(0.2)   missing
Total dose     450 (347) 25–2800
  1. * Logistic regression for repeated observations (GEE). Exchangeable working correlations were used except (for stability reasons) for haloperidol depot and clozapine. For prochlorperazine and sertindol no tests were performed (at most one occasion of use at admission resp. discharge). The results were adjusted for multiple comparisions with Benjamini-Hochberg's method.